{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-044122","form_type":"8-K","ticker":"MIR","cik":"0001809987","company_name":"Mirion Technologies, Inc.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.736710+00:00","generated_at":"2026-05-30T09:22:33.465112+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Mirion Q3 revenue $206.8M (+8.2% YoY); updates FY guidance, narrows FCF range to $65-75M","bullets":["Q3 revenue $206.8M (+8.2% YoY); GAAP net loss $14.0M ($0.07 loss per share); adjusted EPS $0.08 vs $0.05 YoY.","Adjusted EBITDA $45.7M (+17.8% YoY); margin expanded to 22.1% from 20.3%, fifth consecutive quarter of expansion.","Full-year revenue growth guided 6-7% (organic 5-6%); adjusted EBITDA $195-205M unchanged; adjusted FCF narrowed to $65-75M.","CEO cites strong nuclear and cancer care trends; hyperscaler deals position for future growth; Medical organic growth lowered to LSD."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-044122","json":"https://secwatch.observer/filing/0001628280-24-044122.json","markdown":"https://secwatch.observer/filing/0001628280-24-044122.md","text":"https://secwatch.observer/filing/0001628280-24-044122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809987/000162828024044122/0001628280-24-044122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809987/000162828024044122/mir-20241029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:22:33.465112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}